Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

Fig. 5

Pro-inflammatory cytokines keep increased in the sixth month of anti-TB therapy in DR-TB. Levels of cytokines from DS-TB and DR-TB patients were measured in plasma at diagnosis time (0) and 6 months (6) of starting the anti-TB therapy. Pro-inflammatory cytokines: sTNF (A), IFNγ (B), and IL-12 (IL12p70) (C), and anti-inflammatory cytokines: IL-10 (D), TGFβ1 (E), and IL-35 (F) were measured. DS-TB = 13, DR-TB = 7. Dots plots before-after. Wilcoxon matched-pairs test (*p < 0.05)

Back to article page